Published in Infect Control Hosp Epidemiol on November 01, 2005
Influenza vaccination among healthcare workers in a multidisciplinary University hospital in Italy. BMC Public Health (2008) 1.11
Protecting patients, protecting healthcare workers: a review of the role of influenza vaccination. Int Nurs Rev (2011) 1.01
How do primary care physicians in Singapore keep healthy? Singapore Med J (2014) 0.86
Factors affecting uptake of recommended immunizations among health care workers in South Australia. Hum Vaccin Immunother (2015) 0.80
The next battleground for patient safety: influenza immunization of healthcare workers. Infect Control Hosp Epidemiol (2005) 0.79
Nurses' Attitudes towards Enforced Measures to Increase Influenza Vaccination: a Qualitative Study. Influenza Other Respir Viruses (2016) 0.75
Interventions to increase seasonal influenza vaccine coverage in healthcare workers: A systematic review and meta-regression analysis. Hum Vaccin Immunother (2016) 0.75
Reasons why nurses decline influenza vaccination: a qualitative study. BMC Nurs (2017) 0.75
Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J (2005) 2.06
Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine (2010) 1.99
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J (2006) 1.94
Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis (2011) 1.74
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine (2007) 1.66
Three-year surveillance of intussusception in children in Switzerland. Pediatrics (2007) 1.45
Correlation between bacteriologic eradication and clinical cure in acute otitis media. Pediatr Infect Dis J (2004) 1.39
New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin Infect Dis (2004) 1.29
Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? Pediatr Infect Dis J (2012) 1.19
Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr (2005) 1.14
How do physicians immunize their own children? Differences among pediatricians and nonpediatricians. Pediatrics (2005) 1.13
Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013. Pediatr Infect Dis J (2015) 1.12
Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age. Vaccine (2006) 1.12
The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Vaccine (2002) 1.11
Standardised case definitions for adverse events following immunisation. Lancet (2013) 1.09
Addressing the needs and gaps in safety assessment of vaccines during clinical trials in resource limited countries. Vaccine (2011) 1.09
Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection. Pediatr Infect Dis J (2004) 1.09
The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children? Clin Infect Dis (2002) 1.04
Intussusception: incidence and treatment-insights from the nationwide German surveillance. J Pediatr Gastroenterol Nutr (2011) 1.03
Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine (2011) 1.02
Health burden of pertussis in infants and children. Pediatr Infect Dis J (2005) 0.99
The protective role of maternally derived antibodies against Bordetella pertussis in young infants. Pediatr Infect Dis J (2013) 0.97
All that palsies is not Bell's -the need to define Bell's palsy as an adverse event following immunization. Vaccine (2007) 0.95
Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine (2007) 0.94
Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis. Clin Infect Dis (2004) 0.94
Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies. Vaccine (2008) 0.94
Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis. Clin Vaccine Immunol (2010) 0.93
Neonatal and pediatric antimicrobial stewardship programs in Europe-defining the research agenda. Pediatr Infect Dis J (2013) 0.93
Seroprevalence and immunization history of selected vaccine preventable diseases in medical students. Vaccine (2005) 0.93
Comparison of clinical characteristics of influenza and respiratory syncytial virus infection in hospitalised children and adolescents. Eur J Pediatr (2004) 0.93
Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns. Pediatr Infect Dis J (2004) 0.92
Prospective pertussis surveillance in Switzerland, 1991-2006. Vaccine (2011) 0.91
Comparative coverage of supplementary and universally recommended immunizations in children at 24 months of age. Pediatr Infect Dis J (2012) 0.91
The parental appraisal of the morbidity of diarrhea in infants and toddlers (PAMODI) survey. Clin Pediatr (Phila) (2008) 0.90
No temporal association between influenza outbreaks and invasive pneumococcal infections. Arch Dis Child (2007) 0.90
Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis. FEMS Immunol Med Microbiol (2006) 0.90
Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine. Eur J Pediatr (2002) 0.90
A 4-year study on clinical characteristics of children hospitalized with rotavirus gastroenteritis. Eur J Pediatr (2009) 0.89
The development of standardized case definitions and guidelines for adverse events following immunization. Vaccine (2007) 0.88
Metaanalysis of vaccine effectiveness in varicella outbreaks. Vaccine (2007) 0.88
Etiology of aseptic meningitis, peripheral facial nerve palsy, and a combination of both in children. Pediatr Infect Dis J (2010) 0.87
Mycobacterium bohemicum--a cause of paediatric cervical lymphadenitis. Swiss Med Wkly (2004) 0.86
Acceptance and timeliness of standard vaccination in children with chronic neurological deficits in north-western Switzerland. Eur J Pediatr (2005) 0.86
Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems. Vaccine (2008) 0.86
Prevalence of nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) in children a multicenter cross-sectional study. Pediatr Infect Dis J (2007) 0.86
Rotavirus disease in Germany--a prospective survey of very severe cases. Pediatr Infect Dis J (2013) 0.85
Economic evaluation of varicella vaccination in Swiss children and adolescents. Hum Vaccin (2009) 0.85
Clinical findings and unusual epidemiologic characteristics of human metapneumovirus infections in children in the region of Basel, Switzerland. Eur J Pediatr (2007) 0.85
Apnoea and bradycardia in preterm infants following immunisation with pentavalent or hexavalent vaccines. Eur J Pediatr (2005) 0.85
A multicenter, cross-sectional study on the prevalence and risk factors for nasal colonization with Staphylococcus aureus in patients admitted to children's hospitals in Switzerland. Clin Infect Dis (2008) 0.85
Template protocol for clinical trials investigating vaccines--focus on safety elements. Vaccine (2013) 0.84
Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection? Clin Vaccine Immunol (2006) 0.84
Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine (2004) 0.84
Kinetics of maternally acquired anti-hepatitis A antibodies: prediction of waning based on maternal or cord blood antibody levels. Vaccine (2013) 0.84
Reliability of varicella history in children and adolescents. Swiss Med Wkly (2005) 0.83
Adverse events following immunization: perception and evidence. Curr Opin Infect Dis (2007) 0.83
Optimizing antibacterial therapy for community-acquired respiratory tract infections in children in an era of bacterial resistance. Clin Pediatr (Phila) (2004) 0.83
Standardized case definitions of adverse events following immunization (AEFI). Vaccine (2004) 0.83
The Brighton Collaboration: enhancing comparability of vaccine safety data. Pharmacoepidemiol Drug Saf (2003) 0.83
Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland. Vaccine (2003) 0.82
Prospective study on central venous line associated bloodstream infections. Arch Dis Child (2011) 0.82
Prospective surveillance of nosocomial viral infections during and after hospitalization at a university children's hospital. Pediatr Infect Dis J (2010) 0.82
Incidence and Outcome of Group B Streptococcal Sepsis in Infants in Switzerland. Pediatr Infect Dis J (2016) 0.81
Fever following immunization. Expert Rev Vaccines (2005) 0.81
Potential role of fluoroquinolone therapy in childhood otitis media. Pediatr Infect Dis J (2004) 0.81
Human metapneumovirus infections--biannual epidemics and clinical findings in children in the region of Basel, Switzerland. Eur J Pediatr (2009) 0.81
Compliance with antenatal screening for hepatitis B surface antigen carrier status in pregnant women and consecutive procedures in exposed newborns. Eur J Pediatr (2004) 0.81
Prevalence of nosocomial infections in Swiss children's hospitals. Infect Control Hosp Epidemiol (2004) 0.81
The Brighton Collaboration-enhancing vaccine safety. Vaccine (2004) 0.80
Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland. Hum Vaccin (2009) 0.80
Evaluation of the Brighton Collaboration case definition of acute intussusception during active surveillance. Vaccine (2005) 0.78
Vaccinated students with negative enzyme immunoassay results show positive measles virus-specific antibody levels by immunofluorescence and plaque neutralisation tests. J Clin Virol (2007) 0.78
A retrospective analysis of nosocomial viral gastrointestinal and respiratory tract infections. Pediatr Infect Dis J (2012) 0.78
Interstrain antigenic variability of mumps viruses. Clin Infect Dis (2008) 0.77
Health care-associated rotavirus illness in pediatric inpatients in Germany, Austria, and Switzerland. Infect Control Hosp Epidemiol (2006) 0.77
Protection against vaccine-preventable diseases in medical students. Pediatr Infect Dis J (2003) 0.77
Attitudes of pediatricians regarding influenza self-immunization: a survey in a Swiss university children's hospital. Pediatr Infect Dis J (2003) 0.77
Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial. PLoS One (2013) 0.77
Interpretation of primary care physicians' attitude regarding rotavirus immunisation using diffusion of innovation theories. Vaccine (2009) 0.76
Protection against vaccine-preventable diseases in medical students: a follow up. Pediatr Infect Dis J (2014) 0.76
Virosome influenza vaccine in children. Vaccine (2002) 0.76
Pertussis Across the Globe: Recent Epidemiologic Trends From 2000-2013. Pediatr Infect Dis J (2015) 0.76
Comment: clinical implications of endotoxin concentrations in vaccines. Ann Pharmacother (2002) 0.75
Comment on findings of Hodge et al. Respirology (2004) 0.75